DR. REDDY'S LABORATORIES LIMITED Dr. Reddy's Laboratories Ltd. announced the launch of Pemetrexed for Injection, 100 mg and 500 mg Single-Dose Vials, the generic equivalent of ALIMTA® (pemetrexed for injection) in the U.S. Market approved by the U.S. Food and Drug Administration. The ALIMTA® brand and generic had U.S. sales of approximately $1,239 million MAT for the most recent twelve months ending in March 2022 according to IQVIA Health. Dr. Reddy's Pemetrexed for Injection is supplied in 100 mg and 500 mg single-dose vials.
Dr. Reddy’S Laboratories Ltd. Announces the Launch of Pemetrexed for Injection, 100 Mg and 500 Mg Single-Dose Vials, the Generic Equivalent of Alimta® (Pemetrexed for Injection) in the U.S. Market Approved by the U.S. Food and Drug Administration
May 27, 2022 at 10:15 am EDT
Share
Share
© S&P Capital IQ - 2022
